CYP1B1 and non-small cell lung carcinoma: For example, OT resistance can result from altered chromatin architecture induced by CYP1B1/H1.4 in ovarian cancer or by activating error-prone DNA polymerases during replication to repair therapy-induced DNA breaks in non-small cell lung cancer (NSCLC)26.